Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned

Withdrawal of type 2 oral poliovirus vaccine (OPV) in OPV-using countries required regulatory approval for use of inactivated poliovirus vaccine and bivalent OPV in routine immunization. Worldwide, a variety of mechanisms were used by member states, with some differences in approach observed between...

Descripción completa

Detalles Bibliográficos
Autores principales: Decina, Daniela, Fournier-Caruana, Jacqueline, Takane, Marina, Ostad Ali Dehaghi, Razieh, Sutter, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Supplement Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853659/
https://www.ncbi.nlm.nih.gov/pubmed/28838164
http://dx.doi.org/10.1093/infdis/jiw564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853659/
https://www.ncbi.nlm.nih.gov/pubmed/28838164
http://dx.doi.org/10.1093/infdis/jiw564

Ejemplares similares